Diagnostic Dilemmas in Aggressive Large B Cell Neoplasms with Enigmatic Immunohistochemical Profile: How Far Should We Investigate?

Trisomy 18: how far should we go.

Fluctuating asymmetry and animal welfare: how far are we? And how far should we go?

In the associated review, published in this issue of the Journal, Møller and Manning (2003) propose measures of developmental instability, primarily fluctuating asymmetry, for the assessment of animal welfare in agricultural practice. They see the advantages of fluctuating asymmetry in that it provides a single measure of organismal health that ‘‘can be used in all kinds of organisms including ...

Immunohistochemical classification of B cell neoplasms.

Rapid responses http://jcp.bmj.com/cgi/eletter-submit/56/3/193 You can respond to this article at: service Email alerting top right corner of the article Receive free email alerts when new articles cite this article sign up in the box at the Topic collections (13598 articles) Immunology (including allergy) • (1484 articles) Molecular genetics • Articles on similar topics can be found in the f...

Active Surveillance in Prostate Cancer: How Far Should We Go?

24. Russo AL, ChenM-H, Aizer AA, Hattangadi JA, D’Amico AV. Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM). BJU Int. 2012;110 (7):973-979. 25. LeeWR, deGuzman AF, Bare RL, Marshall MG, McCullough DL. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first ...

Carcinoembryonic antigen screening: how far should we go?

INTRODUCTION The role of carcinoembryonic antigen (CEA) in screening has been previously investigated and found to be inefficient because of its low sensitivity and specificity. Nevertheless, it is still used as a tumour marker in health screening packages, often for asymptomatic patients. We aimed to review all asymptomatic patients who were referred to our department for raised CEA, to determ...